About Indio Labs
Indio Labs is a Healthcare company based in Bengaluru (India) founded in 2013 by Siraj Bagwan. Cost-effective biomedical devices for tissue biopsies are developed. Indio Labs has raised $5.14 million across 4 funding rounds from investors including Department of Biotechnology, Vmms Holdings and Abdul Rahman Ali Al Khudair Holding. Indio Labs was last valued at $3.06 million in May 2016. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity in India is Indio Labs Private Limited (U73100KA2013PTC070380).
Company details
Developers of cost-effective biomedical devices. Their BioScoop biopsy system is a device for soft tissue core biopsy. It enables physicians achieve definitive tissue capture using a novel needle design, advanced needle-tissue characterization and automated control. Its other product, BxSeal is a safety feature offered to the biopsy device to assist in concurrently delivering a haemostatic agent inside the biopsy track to reduce the risk of internal haemorrhage.
- Headquarters Bengaluru, India
- Founders Siraj Bagwan
- Stage Minicorn
- SectorsHealthcare
- Website indiolabs.com
- Social LinkedIn X Facebook
- Legal Name Indio Labs Private Limited
- Date of Incorporation 30 Jul, 2013
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹2,570
FY 2021 · +8% YoY
- Net Loss-₹1.8 Lakh
FY 2021 · -7107% margin
- EBITDA-₹76,215
FY 2021 · -2966% margin
- Total Equity Funding$5.14M (USD)
in 4 rounds
- Latest Funding Round$251.71K (USD), Series A
May 2016
- InvestorsDepartment of Biotechnology
& 41 more
Associated legal entities of Indio Labs
Indio Labs is associated with 2 registered companies on The Company Check; the primary company is Indio Labs Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Indio Labs Private Limited CIN U73100KA2013PTC070380 | Active | 30 Jul 2013 | Bangalore, Karnataka | ₹0.0 Cr | 2 | View details | |
| Omya Healthcare Limited CIN U85190KA2009PLC049323 | Active | 09 Mar 2009 | Bengaluru, Karnataka | ₹0.0 Cr | 9 | 4 | View details |
Funding Insights of Indio Labs
Indio Labs has successfully raised a total of $5.14M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $251.71 thousand completed in May 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.14M
- Total Rounds 4
- Last Round Series A — $251,711
- First Round $2.1M
(Jul 2013)
- Investors Count 42
All 4 funding rounds of Indio Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2016 | $251,711 | Series A | $3.06M | Vmms Holdings | – |
| Sep 2014 | $2.79M | Series A | $10.19M | Abdul Rahman Ali Al Khudair Holding | – |
| Jun 2014 | Grant | – | – | ||
| Jul 2013 | $2.1M | Series A | $••••• | Murali Krishna Reddy |
| Date | Valuation | Stage |
|---|---|---|
| May 2016 | $3.06M | •••••••• |
| Sep 2014 | $10.19M | •••••••• |
| Jul 2013 | $••••• | •••••••• |
Full valuation and stage history of Indio Labs
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $3.06M (May 2016). 42 investors in total: 3 institutional and 39 angel.
Investors in Indio Labs
Indio Labs has secured backing from 42 investors, including institutional and angel investors. Prominent investors backing the company include Department of Biotechnology, Vmms Holdings and Abdul Rahman Ali Al Khudair Holding.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| vmmsholdings.tcc.mode | ||||
| abdulrahmanalialkhudairholding.tcc.mode | ||||
Biotechnology research, guidelines, and funding by the Government of India. | 1986 | dbtindia.gov.in | Delhi, India | |
NS Noda Subrya Bhat | unknown_666c62e1137647028 | |||
PR Pradeep Rajan | unknown_279a42a08f1940608 | |||
YP Y Purushothama Reddy | unknown_8c406a88d9094a03a | |||
EI Edukulathur Ittoop Devis | unknown_cfa5ef2dbde24d078 | |||
KP K Parameswara Reddy | unknown_4e3eba08e9eb4f918 | |||
AK Arun Kariyal Parthasarathy | unknown_36778ac8751e44d5b | |||
RN Ramesh Nair | unknown_620cfc04269549e99 |
Investor details for Indio Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Indio Labs Private Limited (Indio Labs)
Indio Labs Private Limited is the primary company behind Indio Labs. The boards of the 2 registered companies of Indio Labs currently have 3 directors; the longest-serving is Ahmed Abdulrahman Ali Alkhudair, appointed in 2017. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ahmed Abdulrahman Ali Alkhudair DIN 07537458 | Director | 13 Mar 2017 | 9 yrs 7 mo | Omya Healthcare Limited |
| Siraj Shoukat Bagwan DIN 06586973 | Managing Director | 26 Apr 2019 | 7 yrs 6 mo | Omya Healthcare Limited, Indio Labs Private Limited |
| Tetali Murali Krishna Reddy DIN 01528801 | CFO | 26 Apr 2019 | 7 yrs 6 mo | Omya Healthcare Limited, Indio Labs Private Limited |
People of Indio Labs
1 people are tracked at Indio Labs (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder & Managing Director | Leadership |
Complete people profiles for Indio Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Indio Labs
Figures of Indio Labs Private Limited, the primary company behind Indio Labs, for FY 2021. Revenue was ₹2,570 (+8% year on year). Net loss was -₹1.8 Lakh (-7107% margin). EBITDA was -₹76,215 (-2966% margin). Revenue has grown at a compounded annual rate of -58% over three years and +18% over five years.
- ₹2,570Revenue · FY 2021 · +8% YoY
- -₹1.8 LakhNet loss · -7107% margin
- -₹76,215EBITDA · -2966% margin
- ₹96 LakhPaid-up capital
- -58%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Indio Labs Private Limited are on its company page.
Detailed financial statements for Indio Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Indio Labs
4 dated milestones of Indio Labs across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Indio Labs is founded.
- Funding First funding round of $2.1M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $252K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Indio Labs
Indio Labs was founded in 2013.
Indio Labs is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Indio Labs is a funded company, having raised a total of $5.14M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2.1M, raised on Jul 2013.
The primary company behind Indio Labs, Indio Labs Private Limited, reported revenue of ₹2,570 for FY 2021, up 8% year on year.
Developers of cost-effective biomedical devices. Their BioScoop biopsy system is a device for soft tissue core biopsy. It enables physicians achieve definitive tissue capture using a novel needle design, advanced needle-tissue characterization and automated control. Its other product, BxSeal is a safety feature offered to the biopsy device to assist in concurrently delivering a haemostatic agent inside the biopsy track to reduce the risk of internal haemorrhage.
Indio Labs has 42 investors. Key investors include Department of Biotechnology, Vmms Holdings, Abdul Rahman Ali Al Khudair Holding, Noda Subrya Bhat, and Pradeep Rajan.
The valuation of Indio Labs is $3.06M as of May 2016.
Indio Labs is associated with 2 legal entities: Indio Labs Private Limited, Omya Healthcare Limited.
The legal entities of Indio Labs currently have 3 directors, including Ahmed Abdulrahman Ali Alkhudair, Tetali Murali Krishna Reddy, Siraj Shoukat Bagwan.